Targeting BRCA2 deficiency with GSK3 inhibitors
<p>BRCA1 and BRCA2 tumour suppressors are essential for homologous recombination-mediated double-strand break repair and replication fork protection. Therefore, BRCA1 and BRCA2 are essential for cell viability. Deactivating mutations in one of these genes lead to genome instability and are ass...
Autor principal: | Zonderland, G |
---|---|
Outros Autores: | Tarsounas, M |
Formato: | Tese |
Publicado em: |
2017
|
Registros relacionados
-
Chlorambucil targets BRCA1/2‐deficient tumours and counteracts PARP inhibitor resistance
por: Tacconi, E, et al.
Publicado em: (2019) -
Chlorambucil targets BRCA1/2‐deficient tumours and counteracts PARP inhibitor resistance
por: Eliana MC Tacconi, et al.
Publicado em: (2019-05-01) -
Targeting BRCA1 and BRCA2 deficiencies with G-quadruplex-interacting compounds
por: Zimmer, J, et al.
Publicado em: (2016) -
Targeting the BRCA1/2 deficient cancer with PARP inhibitors: Clinical outcomes and mechanistic insights
por: Ashwin Ragupathi, et al.
Publicado em: (2023-03-01) -
Novel approaches for targeting BRCA2-deficient tumour cells
por: Tacconi, E
Publicado em: (2015)